Send to

Choose Destination
Ann N Y Acad Sci. 2012 Dec;1275:17-22. doi: 10.1111/j.1749-6632.2012.06780.x.

Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.

Author information

Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA.


Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) is a multicenter, randomized, double blind, placebo-controlled trial that is being conducted under the auspices of the Muscle Study Group. EPITOME is the first randomized control trial in patients with ocular myasthenia and aims to evaluate the efficacy and tolerability of prednisone over a period of four months in patients with newly diagnosed ocular myasthenia whose symptoms have failed to remit in response to a trial of cholinesterase inhibitor therapy.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center